1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type-1 Diabetes Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Rapid-Acting Insulin
1.2.3 Short-Acting Insulin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Type-1 Diabetes Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals & Clinics
1.3.3 Academic & Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Type-1 Diabetes Treatment Market Perspective (2017-2028)
2.2 Type-1 Diabetes Treatment Growth Trends by Region
2.2.1 Type-1 Diabetes Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Type-1 Diabetes Treatment Historic Market Size by Region (2017-2022)
2.2.3 Type-1 Diabetes Treatment Forecasted Market Size by Region (2023-2028)
2.3 Type-1 Diabetes Treatment Market Dynamics
2.3.1 Type-1 Diabetes Treatment Industry Trends
2.3.2 Type-1 Diabetes Treatment Market Drivers
2.3.3 Type-1 Diabetes Treatment Market Challenges
2.3.4 Type-1 Diabetes Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Type-1 Diabetes Treatment Players by Revenue
3.1.1 Global Top Type-1 Diabetes Treatment Players by Revenue (2017-2022)
3.1.2 Global Type-1 Diabetes Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Type-1 Diabetes Treatment Revenue
3.4 Global Type-1 Diabetes Treatment Market Concentration Ratio
3.4.1 Global Type-1 Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type-1 Diabetes Treatment Revenue in 2021
3.5 Type-1 Diabetes Treatment Key Players Head office and Area Served
3.6 Key Players Type-1 Diabetes Treatment Product Solution and Service
3.7 Date of Enter into Type-1 Diabetes Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Type-1 Diabetes Treatment Breakdown Data by Type
4.1 Global Type-1 Diabetes Treatment Historic Market Size by Type (2017-2022)
4.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2023-2028)
5 Type-1 Diabetes Treatment Breakdown Data by Application
5.1 Global Type-1 Diabetes Treatment Historic Market Size by Application (2017-2022)
5.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Type-1 Diabetes Treatment Market Size (2017-2028)
6.2 North America Type-1 Diabetes Treatment Market Size by Type
6.2.1 North America Type-1 Diabetes Treatment Market Size by Type (2017-2022)
6.2.2 North America Type-1 Diabetes Treatment Market Size by Type (2023-2028)
6.2.3 North America Type-1 Diabetes Treatment Market Share by Type (2017-2028)
6.3 North America Type-1 Diabetes Treatment Market Size by Application
6.3.1 North America Type-1 Diabetes Treatment Market Size by Application (2017-2022)
6.3.2 North America Type-1 Diabetes Treatment Market Size by Application (2023-2028)
6.3.3 North America Type-1 Diabetes Treatment Market Share by Application (2017-2028)
6.4 North America Type-1 Diabetes Treatment Market Size by Country
6.4.1 North America Type-1 Diabetes Treatment Market Size by Country (2017-2022)
6.4.2 North America Type-1 Diabetes Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Type-1 Diabetes Treatment Market Size (2017-2028)
7.2 Europe Type-1 Diabetes Treatment Market Size by Type
7.2.1 Europe Type-1 Diabetes Treatment Market Size by Type (2017-2022)
7.2.2 Europe Type-1 Diabetes Treatment Market Size by Type (2023-2028)
7.2.3 Europe Type-1 Diabetes Treatment Market Share by Type (2017-2028)
7.3 Europe Type-1 Diabetes Treatment Market Size by Application
7.3.1 Europe Type-1 Diabetes Treatment Market Size by Application (2017-2022)
7.3.2 Europe Type-1 Diabetes Treatment Market Size by Application (2023-2028)
7.3.3 Europe Type-1 Diabetes Treatment Market Share by Application (2017-2028)
7.4 Europe Type-1 Diabetes Treatment Market Size by Country
7.4.1 Europe Type-1 Diabetes Treatment Market Size by Country (2017-2022)
7.4.2 Europe Type-1 Diabetes Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Type-1 Diabetes Treatment Market Size (2017-2028)
8.2 Asia-Pacific Type-1 Diabetes Treatment Market Size by Type
8.2.1 Asia-Pacific Type-1 Diabetes Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Type-1 Diabetes Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Type-1 Diabetes Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Type-1 Diabetes Treatment Market Size by Application
8.3.1 Asia-Pacific Type-1 Diabetes Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Type-1 Diabetes Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Type-1 Diabetes Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region
8.4.1 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Type-1 Diabetes Treatment Market Size (2017-2028)
9.2 Latin America Type-1 Diabetes Treatment Market Size by Type
9.2.1 Latin America Type-1 Diabetes Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Type-1 Diabetes Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Type-1 Diabetes Treatment Market Share by Type (2017-2028)
9.3 Latin America Type-1 Diabetes Treatment Market Size by Application
9.3.1 Latin America Type-1 Diabetes Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Type-1 Diabetes Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Type-1 Diabetes Treatment Market Share by Application (2017-2028)
9.4 Latin America Type-1 Diabetes Treatment Market Size by Country
9.4.1 Latin America Type-1 Diabetes Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Type-1 Diabetes Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Type-1 Diabetes Treatment Market Size (2017-2028)
10.2 Middle East & Africa Type-1 Diabetes Treatment Market Size by Type
10.2.1 Middle East & Africa Type-1 Diabetes Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Type-1 Diabetes Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Type-1 Diabetes Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Type-1 Diabetes Treatment Market Size by Application
10.3.1 Middle East & Africa Type-1 Diabetes Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Type-1 Diabetes Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Type-1 Diabetes Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country
10.4.1 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Type-1 Diabetes Treatment Introduction
11.1.4 Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.1.5 Astellas Pharma Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Type-1 Diabetes Treatment Introduction
11.2.4 Merck Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Type-1 Diabetes Treatment Introduction
11.3.4 Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.3.5 Eli Lilly Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Type-1 Diabetes Treatment Introduction
11.4.4 Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.4.5 Novo Nordisk Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Type-1 Diabetes Treatment Introduction
11.5.4 Sanofi Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.5.5 Sanofi Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Type-1 Diabetes Treatment Introduction
11.6.4 AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 Boehringer Ingelheim GmbH
11.7.1 Boehringer Ingelheim GmbH Company Details
11.7.2 Boehringer Ingelheim GmbH Business Overview
11.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Introduction
11.7.4 Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.7.5 Boehringer Ingelheim GmbH Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Type-1 Diabetes Treatment Introduction
11.8.4 Novartis Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.8.5 Novartis Recent Developments
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Type-1 Diabetes Treatment Introduction
11.9.4 Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.9.5 Pfizer Inc. Recent Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Type-1 Diabetes Treatment Introduction
11.10.4 Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.10.5 Abbott Laboratories Recent Developments
11.11 Mannkind Corporation
11.11.1 Mannkind Corporation Company Details
11.11.2 Mannkind Corporation Business Overview
11.11.3 Mannkind Corporation Type-1 Diabetes Treatment Introduction
11.11.4 Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.11.5 Mannkind Corporation Recent Developments
11.12 Braun Melsungen AG
11.12.1 Braun Melsungen AG Company Details
11.12.2 Braun Melsungen AG Business Overview
11.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Introduction
11.12.4 Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.12.5 Braun Melsungen AG Recent Developments
11.13 Macrogenics, Inc.
11.13.1 Macrogenics, Inc. Company Details
11.13.2 Macrogenics, Inc. Business Overview
11.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Introduction
11.13.4 Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022)
11.13.5 Macrogenics, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Type-1 Diabetes Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Rapid-Acting Insulin
Table 3. Key Players of Short-Acting Insulin
Table 4. Key Players of Others
Table 5. Global Type-1 Diabetes Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Type-1 Diabetes Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Type-1 Diabetes Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Type-1 Diabetes Treatment Market Share by Region (2017-2022)
Table 9. Global Type-1 Diabetes Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Type-1 Diabetes Treatment Market Share by Region (2023-2028)
Table 11. Type-1 Diabetes Treatment Market Trends
Table 12. Type-1 Diabetes Treatment Market Drivers
Table 13. Type-1 Diabetes Treatment Market Challenges
Table 14. Type-1 Diabetes Treatment Market Restraints
Table 15. Global Type-1 Diabetes Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Type-1 Diabetes Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Type-1 Diabetes Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2021)
Table 18. Ranking of Global Top Type-1 Diabetes Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Type-1 Diabetes Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Type-1 Diabetes Treatment Product Solution and Service
Table 22. Date of Enter into Type-1 Diabetes Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Type-1 Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Type-1 Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Type-1 Diabetes Treatment Revenue Share by Application (2017-2022)
Table 30. Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Type-1 Diabetes Treatment Revenue Share by Application (2023-2028)
Table 32. North America Type-1 Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Type-1 Diabetes Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Type-1 Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Type-1 Diabetes Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Type-1 Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Type-1 Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Type-1 Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Type-1 Diabetes Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Type-1 Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Type-1 Diabetes Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Type-1 Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Type-1 Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Type-1 Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Type-1 Diabetes Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Type-1 Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Type-1 Diabetes Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Type-1 Diabetes Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Type-1 Diabetes Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Type-1 Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Type-1 Diabetes Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Type-1 Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Type-1 Diabetes Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Type-1 Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Type-1 Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Type-1 Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Type-1 Diabetes Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Type-1 Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Type-1 Diabetes Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Type-1 Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Type-1 Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. Astellas Pharma Company Details
Table 63. Astellas Pharma Business Overview
Table 64. Astellas Pharma Type-1 Diabetes Treatment Product
Table 65. Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 66. Astellas Pharma Recent Developments
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Type-1 Diabetes Treatment Product
Table 70. Merck Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 71. Merck Recent Developments
Table 72. Eli Lilly Company Details
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Type-1 Diabetes Treatment Product
Table 75. Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 76. Eli Lilly Recent Developments
Table 77. Novo Nordisk Company Details
Table 78. Novo Nordisk Business Overview
Table 79. Novo Nordisk Type-1 Diabetes Treatment Product
Table 80. Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 81. Novo Nordisk Recent Developments
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Type-1 Diabetes Treatment Product
Table 85. Sanofi Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 86. Sanofi Recent Developments
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Type-1 Diabetes Treatment Product
Table 90. AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 91. AstraZeneca Recent Developments
Table 92. Boehringer Ingelheim GmbH Company Details
Table 93. Boehringer Ingelheim GmbH Business Overview
Table 94. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product
Table 95. Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 96. Boehringer Ingelheim GmbH Recent Developments
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Type-1 Diabetes Treatment Product
Table 100. Novartis Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 101. Novartis Recent Developments
Table 102. Pfizer Inc. Company Details
Table 103. Pfizer Inc. Business Overview
Table 104. Pfizer Inc. Type-1 Diabetes Treatment Product
Table 105. Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 106. Pfizer Inc. Recent Developments
Table 107. Abbott Laboratories Company Details
Table 108. Abbott Laboratories Business Overview
Table 109. Abbott Laboratories Type-1 Diabetes Treatment Product
Table 110. Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 111. Abbott Laboratories Recent Developments
Table 112. Mannkind Corporation Company Details
Table 113. Mannkind Corporation Business Overview
Table 114. Mannkind Corporation Type-1 Diabetes Treatment Product
Table 115. Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 116. Mannkind Corporation Recent Developments
Table 117. Braun Melsungen AG Company Details
Table 118. Braun Melsungen AG Business Overview
Table 119. Braun Melsungen AG Type-1 Diabetes Treatment Product
Table 120. Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 121. Braun Melsungen AG Recent Developments
Table 122. Macrogenics, Inc. Company Details
Table 123. Macrogenics, Inc. Business Overview
Table 124. Macrogenics, Inc. Type-1 Diabetes Treatment Product
Table 125. Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2017-2022) & (US$ Million)
Table 126. Macrogenics, Inc. Recent Developments
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Type-1 Diabetes Treatment Market Share by Type: 2021 VS 2028
Figure 2. Rapid-Acting Insulin Features
Figure 3. Short-Acting Insulin Features
Figure 4. Others Features
Figure 5. Global Type-1 Diabetes Treatment Market Share by Application: 2021 VS 2028
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Academic & Research Institutes Case Studies
Figure 8. Type-1 Diabetes Treatment Report Years Considered
Figure 9. Global Type-1 Diabetes Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Type-1 Diabetes Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Type-1 Diabetes Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Type-1 Diabetes Treatment Market Share by Players in 2021
Figure 13. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Type-1 Diabetes Treatment Revenue in 2021
Figure 15. North America Type-1 Diabetes Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Type-1 Diabetes Treatment Market Size Market Share by Type (2017-2028)
Figure 17. North America Type-1 Diabetes Treatment Market Size Market Share by Application (2017-2028)
Figure 18. North America Type-1 Diabetes Treatment Market Size Share by Country (2017-2028)
Figure 19. United States Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Type-1 Diabetes Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Type-1 Diabetes Treatment Market Size Market Share by Type (2017-2028)
Figure 23. Europe Type-1 Diabetes Treatment Market Size Market Share by Application (2017-2028)
Figure 24. Europe Type-1 Diabetes Treatment Market Size Share by Country (2017-2028)
Figure 25. Germany Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Type-1 Diabetes Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Type-1 Diabetes Treatment Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Type-1 Diabetes Treatment Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Type-1 Diabetes Treatment Market Size Share by Region (2017-2028)
Figure 35. China Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Type-1 Diabetes Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Type-1 Diabetes Treatment Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Type-1 Diabetes Treatment Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Type-1 Diabetes Treatment Market Size Share by Country (2017-2028)
Figure 45. Mexico Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Type-1 Diabetes Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Type-1 Diabetes Treatment Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Type-1 Diabetes Treatment Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Type-1 Diabetes Treatment Market Size Share by Country (2017-2028)
Figure 51. Turkey Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Type-1 Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Astellas Pharma Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 55. Merck Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 56. Eli Lilly Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 57. Novo Nordisk Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 58. Sanofi Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 59. AstraZeneca Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 60. Boehringer Ingelheim GmbH Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 62. Pfizer Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 63. Abbott Laboratories Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 64. Mannkind Corporation Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 65. Braun Melsungen AG Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 66. Macrogenics, Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed